Loading company…
Belfast-based medical technology company making non-invasive neurostimulation devices for insomnia and anxiety.
Neurovalens Limited develops medical devices, mainly non-invasive neurostimulation products for chronic insomnia and generalized anxiety disorder. Founded in 2013 and based in Belfast, UK, by CEO Jason McKeown and Paul D. McGeoch, it raised GBP 7 million in equity and debt funding in August 2025, led by new investor Investment Fund for Northern Ireland, with returning investors WhiteRock Capital Partners, IQ Capital, Innovation Ulster and ACF Investors. The funds will support sales growth and further US regulatory approvals.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in